Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Ventas
  6. Summary
    VTR   US92276F1003

VENTAS

(VTR)
  Report
Delayed Nyse  -  04:04 2022-06-29 pm EDT
51.56 USD   +0.88%
06/23Credit Suisse Initiates 24 REIT Stocks, Names 5 Top Picks, Says Inflation Protection to Partially Offset Impact of Rising Rates
MT
06/22BMO Capital Lowers Ventas' Price Target to $57 From $64, Maintains Outperform Rating
MT
06/22Pamela Boneham Joins Ventas Investment Management Platform as Senior Strategic Advisor
BU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/23/2022 06/24/2022 06/27/2022 06/28/2022 06/29/2022 Date
49.94(c) 51.23(c) 51.57(c) 51.11(c) 51.56 Last
1 226 956 2 377 114 1 291 221 1 430 957 1 608 159 Volume
+0.38% +2.58% +0.66% -0.89% +0.88% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 4 175 M - -
Net income 2022 66,9 M - -
Net Debt 2022 12 803 M - -
P/E ratio 2022 299x
Yield 2022 3,50%
Sales 2023 4 503 M - -
Net income 2023 183 M - -
Net Debt 2023 12 025 M - -
P/E ratio 2023 122x
Yield 2023 3,78%
Capitalization 20 608 M 20 608 M -
EV / Sales 2022 8,00x
EV / Sales 2023 7,25x
Nbr of Employees 434
Free-Float 99,5%
More Financials
Company
Ventas, Inc. specializes in owning and managing healthcare and medical-residential facilities. At the end of 2021, the group's portfolio included 1,242 assets consisting of rest homes (821), medical office facilities (313), laboratories and research facilities (43), rehabilitation and long-term acute care facilities (36), skilled nursing facilities (16), medical and surgical facilities (13). Net sales are... 
Read more
Sector
Specialized REITs
Calendar
06/30Ex-dividend day for
More about the company
Ratings of Ventas
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A
More Ratings
All news about VENTAS
06/23Credit Suisse Initiates 24 REIT Stocks, Names 5 Top Picks, Says Inflation Protection to..
MT
06/22BMO Capital Lowers Ventas' Price Target to $57 From $64, Maintains Outperform Rating
MT
06/22Pamela Boneham Joins Ventas Investment Management Platform as Senior Strategic Advisor
BU
06/22Ventas, Inc. Appoints Pamela Boneham as Senior Strategic Advisor to Its Ventas Investme..
CI
06/08TRANSCRIPT : Ventas, Inc. Presents at Nareit’s REITweek: 2022 Investor Conference, Ju..
CI
06/06Ventas to Present at Nareit's REITweek 2022 Investor Conference
BU
06/01VENTAS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Even..
AQ
06/01Morgan Stanley Adjusts Ventas' Price Target to $59 from $61.50, Keeps Equalweight Ratin..
MT
05/31Berenberg Bank Adjusts Ventas' Price Target to $60 From $57, Maintains Hold Rating
MT
05/25Ventas Maintains Quarterly Dividend at $0.45 a Share, Payable July 14 to Shareholders a..
MT
05/25Ventas Declares Second Quarter 2022 Dividend of $0.45 per Common Share
BU
05/25Ventas, Inc. Declares Second Quarter 2022 Dividend, Payable on July 14, 2022
CI
05/20RBC Lifts Price Target on Ventas to $63 From $62, Maintains Outperform Rating
MT
05/19Ventas Named a Top Corporate Citizen of 2022 by 3BL Media
BU
05/18Ventas's Outlook Revised by S&P Global Ratings to Stable
BU
More news
News in other languages on VENTAS
06/22Ventas, Inc. nomme Pamela Boneham au poste de conseillère stratégique principale pour s..
05/25Ventas, Inc. Déclare un dividende pour le deuxième trimestre 2022, payable le 14 juille..
05/06Ventas affiche des revenus et des rentrées d'argent normalisés plus élevés au premier t..
05/05Ventas, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2022
05/05Earnings Flash (VTR) VENTAS affiche un chiffre d'affaires de 1,02 milliard de dollars p..
More news
Analyst Recommendations on VENTAS
More recommendations
Chart VENTAS
Duration : Period :
Ventas Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends VENTAS
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 51,56 $
Average target price 63,18 $
Spread / Average Target 22,5%
EPS Revisions
Managers and Directors
Debra A. Cafaro Chairman & Chief Executive Officer
Robert F. Probst Chief Financial Officer & Executive Vice President
Bhavana Devulapally Chief Information Officer & Senior Vice President
Carey S. Roberts EVP, General Counsel, Ethics & Compliance Officer
John D. Cobb Chief Investment Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
VENTAS-0.02%20 428
WELLTOWER INC.-3.03%37 625
HEALTHPEAK PROPERTIES, INC.-29.43%13 743
MEDICAL PROPERTIES TRUST, INC.-33.47%9 344
OMEGA HEALTHCARE INVESTORS, INC.-1.49%6 857
HEALTHCARE TRUST OF AMERICA, INC.-16.59%6 380